These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-004018-42 A phase III study comparing anastrozole, letrozole and exemestane, upfront (for 5 years) or sequentially (for 3 years after 2 years of tamoxifen), as adjuvant treatment of postmenopausal patients wit... not-yet-due
Ongoing 2006-005842-35 Efficacy and safety of treatment with N-butyl-deoxynojirimycin (NB-DNJ-miglustat) in patients with Niemann-Pick disease type C. not-yet-due
Ongoing 2007-006119-22 Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate. not-yet-due
Ongoing 2008-000804-10 Valsartan 160 mg and hydrochlorothiazide 25 mg in subject suffering from arterial hypertension stage 1 or high normal with organ damage not-yet-due
Ongoing 2008-000824-20 Effects of ezetimibe in association with statins on postprandial lipemia in type 2 diabetic patients not-yet-due
Ongoing 2008-001151-22 ALEMTUZUMAB AND LOW-DOSE CYCLOSPORINE-A AS ALTERNATIVE IMMUNOSUPPRESSIVE TREATMENT FOR SEVERE APLASTIC ANEMIA (SAA) AND SINGLE-LINEAGE APLASTIC PATIENTS. not-yet-due
Ongoing 2008-004110-26 UTILIZZO DEL QUIXIL NELL’INTERVENTO CHIRURGICO DI ERNIOPLASTICA INGUINALE: PROTOCOLLO PER ANALISI FARMACOECONOMICA MEDIANTE STUDIO MULTICENTRICO PROSPETTICO RANDOMIZZATO. not-yet-due
Ongoing 2008-006183-11 Multicenter, Open-Label, Single Arm Phase II Clinical Trial of Dasatinib in the Treatment of Systemic Mastocytosis (SM) not-yet-due
Ongoing 2008-007447-14 GH-IGF-I status and Multiple Sclerosis: clinical implications (a prevalence study). Asse GH-IGF-1 e Sclerosi Multipla: implicazioni cliniche (studio di prevalenza) not-yet-due
Ongoing 2009-010945-30 Prospective, Randomized, Controlled, Double Blind Study on the Effectiveness of Movicol (PEG 3350) versus SedaStip (acacia fiber, psyllium fiber (Plantago ovata), fructose) in the Treatment of Chronic... not-yet-due
Ongoing 2009-011289-27 Probiotics in Cystic Fibrosis not-yet-due
Ongoing 2009-015875-28 Modulation of intestinal and extraintestinal inflammation in infants with Cystic Fibrosis by early modification of intestinal microflora not-yet-due
Ongoing 2009-016317-20 PILOT STUDY TO ASSESS SAFETY AND TOLERABILITY OF LITHIUM ON SPINOCEREBELLAR ATAXIA OF TYPE 2 not-yet-due
Ongoing 2009-016377-15 DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO TEST THE EFFICACY, SAFETY AND TOLERABILITY OF LITHIUM IN MULTIPLE SYSTEM ATROPHY not-yet-due
Not reported 2009-017011-16 Treatment of the low IGF-1 syndrome associated with Chronic Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study 2012-02-08 due-trials
Ongoing 2010-019809-42 Efficacy of methylergometrine daily administration in puerperium not-yet-due
Ongoing 2010-023481-41 Evaluation of long term risk-benefit profile of levothyroxin treatment in children with congenital hypothyroidism:influence of initial levothyroxine dose on neurodevelopment, growth, cardiovascular an... not-yet-due
Ongoing 2010-024647-32 Combined enzyme enhancement therapy (EET) and enzyme replacement therapy (ERT) in patients with Pompe disease not-yet-due
Not reported 2011-006156-37 A double-blind, randomized, placebo-controlled, clinical trial to test the efficacy of Epoetin alfa on physical performance of Friedreich Ataxia patients. Studio in doppio-cieco, randomizzato, cont... 2014-12-16 due-trials
Completed, but no date Terminated 2012-001100-38 Antagonists of Angiotensin II Receptors in sepsis Antagonisti dei recettori dell'angiotensina II nella sepsi bad-data
Ongoing 2012-001653-13 New Therapeutic Options for the Maintenance of Remission of the Ulcerative Colitis in Pediatric Patients Mantenimento della remissione nella rettocolite ulcerosa in età pediatrica: nuove strategie ... not-yet-due
Ongoing 2012-003514-14 HYPOVITAMINOSIS D AND ORGAN DAMAGE IN PATIENTS WITH HYPERTENSION: EFFECTS OF SUPPLEMENTATION WITH CHOLECALCIFEROL IPOVITAMINOSI D E DANNO D'ORGANO IN PAZIENTI CON IPERTENSIONE ARTERIOSA: EFFETTI DE... not-yet-due
Ongoing 2013-001312-30 Long term effects of selective beta1-adrenoceptor blockade with bisoprolol on hospital readmissions of elderly patients with coexisting heart failure and chronic obstructive pulmonary disease: a multi... not-yet-due
Ongoing 2014-004386-24 Effect of GH receptor antagonist on insulin resistance associated with acromegaly Effetto dell¿antagonista del recettore del GH (pegvisomant) sul metabolismo glucidico in pazienti affetti da acrome... not-yet-due
Ongoing 2015-000570-35 Prophylaxis of Hepatitis B reactivation in patients with HBV occult infection and rheumatological diseases candidates to immune suppressive treatments of finite duration. PROFILASSI DELLA RIATTIVAZ... not-yet-due
Completed, but no date, and reported results Terminated 2016-004159-56 Efficacy and safety of mesalazine, rifaximin, alone or as extemporary combination, in the treatment of symptomatic uncomplicated diverticular disease of colon: multi-centre, randomised, double-blind, ... bad-data
Ongoing 2020-005098-29 Novel therapeutic strategies to reduce coronary microvascular obstruction and to OPTImize non-culprit stenoses revascularization in ST-Elevation acute Myocardial Infarction Randomized, no-profit, ope... not-yet-due